|
1
|
Ostrom QT, Gittleman H, Truitt G, Boscia
A, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical report:
Primary brain and other central nervous system tumors diagnosed in
the United States in 2011–2015. Neuro Oncol. 20 (Suppl 4):iv1–iv86.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vigneswaran K, Neill S and Hadjipanayis
CG: Beyond the World Health Organization grading of infiltrating
gliomas: Advances in the molecular genetics of glioma
classification. Ann Transl Med. 3:952015.PubMed/NCBI
|
|
3
|
National Brain Tumor Association, . Quick
brain tumor facts. 2018.Available at: http:
//braintumor.org/brain-tumor-information/brain-tumor-facts/.
November 27–2017
|
|
4
|
American Brain Tumor Association (ABTA), .
Brain tumor statistics. 2017.Available at:
http://www.abta.org/about-us/news/brain-tumor-statistics/.
22–November. 2017
|
|
5
|
McNeill KA: Epidemiology of brain tumors.
Neurol Clin. 34:981–998. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barone F, Alberio N, Iacopino DG,
Giammalva GR, D'Arrigo C, Tagnese W, Graziano F, Cicero S and
Maugeri R: Brain mapping as helpful tool in brain glioma surgical
treatment-toward the ‘Perfect Surgery’? Brain Sci. 8:1922018.
View Article : Google Scholar
|
|
7
|
Ostrom QT, Gittleman H, Liao P,
Vecchione-Koval T, Wolinsky Y, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and other central nervous
system tumors diagnosed in the United States in 2010–2014. Neuro
Oncol. 19 (Suppl 5):v1–v88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Venur VA, Peereboom DM and Ahluwalia MS:
Current medical treatment of glioblastoma. Cancer Treat Res.
163:103–115. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kang JH and Adamson C: Novel
chemotherapeutics and other therapies for treating high-grade
glioma. Expert Opin Investig Drugs. 24:1361–1379. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hauptman N and Glavač D: Long non-coding
RNA in cancer. Int J Mol Sci. 14:4655–4669. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sotillo E and Thomas-Tikhonenko A: The
long reach of noncoding RNAs. Nat Genet. 43:616–617. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mercer TR and Mattick JS: Structure and
function of long noncoding RNAs in epigenetic regulation. Nat
Struct Mol Biol. 20:300–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng Y and Croce CM: The role of MicroRNAs
in human cancer. Signal Transduct Target Ther. 1:150042016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu J, Lichtenberg T, Hoadley KA, Poisson
LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee
AV, et al: An integrated TCGA pan-cancer clinical data resource to
drive high-quality survival outcome analytics. Cell.
173:400–416.e11. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Anders S and Huber W: Differential
expression analysis for sequence count data. Genome Biol.
11:R1062010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fromm B, Billipp T, Peck LE, Johansen M,
Tarver JE, King BL, Newcomb JM, Sempere LF, Flatmark K, Hovig E and
Peterson KJ: A uniform system for the annotation of vertebrate
microRNA genes and the evolution of the human microRNAome. Annu Rev
Genet. 49:213–242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chou CH, Chang NW, Shrestha S, Hsu SD, Lin
YL, Lee WH, Yang CD, Hong HC, Wei TY, Tu SJ, et al: miRTarBase
2016: Updates to the experimentally validated miRNA-target
interactions database. Nucleic Acids Res. 44(D1): D239–D247. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wong N and Wang X: miRDB: An online
resource for microRNA target prediction and functional annotations.
Nucleic Acids Res. 43((Database issue)): D146–D152. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and
Lin CY: cytoHubba: Identifying hub objects and sub-networks from
complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chan JJ and Tay Y: Noncoding RNA:RNA
regulatory networks in cancer. Int J Mol Sci. 19:13102018.
View Article : Google Scholar
|
|
25
|
Wang X, Arai S, Song X, Reichart D, Du K,
Pascual G, Tempst P, Rosenfeld MG, Glass CK and Kurokawa R: Induced
ncRNAs allosterically modify RNA-binding proteins in cis to inhibit
transcription. Nature. 454:126–130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tian S, Liu W, Pan Y and Zhan S: Long
non-coding RNA Linc00320 inhibits glioma cell proliferation through
restraining Wnt/β-catenin signaling. Biochem Biophys Res Commun.
508:458–464. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu C, Liu R, Zhang D, Deng Q, Liu B, Chao
HP, Rycaj K, Takata Y, Lin K, Lu Y, et al: MicroRNA-141 suppresses
prostate cancer stem cells and metastasis by targeting a cohort of
pro-metastasis genes. Nat Commun. 8:142702017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shi L, Zhang J, Pan T, Zhou J, Gong W, Liu
N, Fu Z and You Y: MiR-125b is critical for the suppression of
human U251 glioma stem cell proliferation. Brain Res. 1312:120–126.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang L, Shi ZM, Jiang CF, Liu X, Chen QD,
Qian X, Li DM, Ge X, Wang XF, Liu LZ, et al: MiR-143 acts as a
tumor suppressor by targeting N-RAS and enhances
temozolomide-induced apoptosis in glioma. Oncotarget. 5:5416–5427.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu X, Bao Z, Liu Y, Ji J and Liu N:
MicroRNA-98 attenuates cell migration and invasion in glioma by
directly targeting Pre-B cell leukemia homeobox 3. Cell Mol
Neurobiol. 37:1359–1371. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Anwar SL, Krech T, Hasemeier B, Schipper
E, Schweitzer N, Vogel A, Kreipe H, Buurman R, Skawran B and
Lehmann U: hsa-mir-183 is frequently methylated and related to poor
survival in human hepatocellular carcinoma. World J Gastroenterol.
23:1568–1575. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang BL, Dong FL, Guo TW, Gu XH, Huang LY
and Gao DS: MiRNAs mediate GDNF-induced proliferation and migration
of glioma cells. Cell Physiol Biochem. 44:1923–1938. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li HY, Li YM, Li Y, Shi XW and Chen H:
Circulating microRNA-137 is a potential biomarker for human
glioblastoma. Eur Rev Med Pharmacol Sci. 20:3599–3604.
2016.PubMed/NCBI
|
|
35
|
Yang W, Bai J, Liu D, Wang S, Zhao N, Che
R and Zhang H: MiR-93-5p up-regulation is involved in non-small
cell lung cancer cells proliferation and migration and poor
prognosis. Gene. 647:13–20. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li HY, Liang JL, Kuo YL, Lee HH, Calkins
MJ, Chang HT, Lin FC, Chen YC, Hsu TI, Hsiao M, et al:
miR-105/93-3p promotes chemoresistance and circulating
miR-105/93-3p acts as a diagnostic biomarker for triple negative
breast cancer. Breast Cancer Res. 19:1332017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao Y, Sun L, Wu Z and Chen X:
Over-expression of miR-497 promotes the proliferation of U87 glioma
cells by targeting neuregulin receptor degradation protein 1. Xi
Bao Yu Fen Zi Mian Yi Xue Za Zhi. 33:1051–1055. 2017.(In Chinese).
PubMed/NCBI
|
|
38
|
Feng F, Kuai D, Wang H, Li T, Miao W, Liu
Y and Fan Y: Reduced expression of microRNA-497 is associated with
greater angiogenesis and poor prognosis in human gliomas. Hum
Pathol. 58:47–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jeon H, Kang YH, Yoo SM, Park MJ, Park JB,
Lee SH and Lee MS: Kaposi's sarcoma-associated herpesvirus
infection modulates the proliferation of glioma stem-like cells. J
Microbiol Biotechnol. 28:165–174. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chan PK, Ng HK, Cheung JL and Cheng AF:
Survey for the presence and distribution of human herpesvirus 8 in
healthy brain. J Clin Microbiol. 38:2772–2773. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Merelli E, Bedin R, Sola P, Barozzi P,
Mancardi GL, Ficarra G and Franchini G: Human herpes virus 6 and
human herpes virus 8 DNA sequences in brains of multiple sclerosis
patients, normal adults and children. J Neurol. 244:450–454. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
McFaline-Figueroa JR and Wen PY: The viral
connection to glioblastoma. Curr Infect Dis Rep. 19:52017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lee CG, Park GY, Han YK, Lee JH, Chun SH,
Park HY, Lim KH, Kim EG, Choi YJ, Yang K and Lee CW: Roles of
14-3-3η in mitotic progression and its potential use as a
therapeutic target for cancers. Oncogene. 32:1560–1569. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jin J, Smith FD, Stark C, Wells CD,
Fawcett JP, Kulkarni S, Metalnikov P, O'Donnell P, Taylor P, Taylor
L, et al: Proteomic, functional, and domain-based analysis of in
vivo 14-3-3 binding proteins involved in cytoskeletal regulation
and cellular organization. Curr Biol. 14:1436–1450. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mackintosh C: Dynamic interactions between
14-3-3 proteins and phosphoproteins regulate diverse cellular
processes. Biochem J. 381:329–342. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pećina-Šlaus N, Kafka A, Gotovac Jerčić K,
Logara M, Bukovac A, Bakarić R and Borovečki F: Comparable genomic
copy number aberrations differ across astrocytoma malignancy
grades. Int J Mol Sci. 20:12512019. View Article : Google Scholar
|
|
47
|
Xu X, Cai N, Zhi T, Bao Z, Wang D, Liu Y,
Jiang K, Fan L, Ji J and Liu N: MicroRNA-1179 inhibits glioblastoma
cell proliferation and cell cycle progression via directly
targeting E2F transcription factor 5. Am J Cancer Res. 7:1680–1692.
2017.PubMed/NCBI
|
|
48
|
Zhang Y, Han D, Wei W, Cao W, Zhang R,
Dong Q, Zhang J, Wang Y and Liu N: MiR-218 inhibited growth and
metabolism of human glioblastoma cells by directly targeting E2F2.
Cell Mol Neurobiol. 35:1165–1173. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Music D, Dahlrot RH, Hermansen SK,
Hjelmborg J, de Stricker K, Hansen S and Kristensen BW: Expression
and prognostic value of the WEE1 kinase in gliomas. J Neurooncol.
127:381–389. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Krell A, Wolter M, Stojcheva N, Hertler C,
Liesenberg F, Zapatka M, Weller M, Malzkorn B and Reifenberger G:
MiR-16-5p is frequently down-regulated in astrocytic gliomas and
modulates glioma cell proliferation, apoptosis, and response to
cytotoxic therapy. Neuropathol Appl Neurobiol. 45:441–458.
2019.PubMed/NCBI
|
|
51
|
Yang C, Wang C, Chen X, Chen S, Zhang Y,
Zhi F, Wang J, Li L, Zhou X, Li N, et al: Identification of seven
serum microRNAs from a genome-wide serum microRNA expression
profile as potential noninvasive biomarkers for malignant
astrocytomas. Int J Cancer. 132:116–127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hui W, Yuntao L, Lun L, WenSheng L,
ChaoFeng L, HaiYong H and Yueyang B: MicroRNA-195 inhibits the
proliferation of human glioma cells by directly targeting cyclin D1
and cyclin E1. PLoS One. 8:e549322013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lakomy R, Sana J, Hankeova S, Fadrus P,
Kren L, Lzicarova E, Svoboda M, Dolezelova H, Smrcka M, Vyzula R,
et al: MiR-195, miR-196b, miR-181c, miR-21 expression levels and
O-6-methylguanine-DNA methyltransferase methylation status are
associated with clinical outcome in glioblastoma patients. Cancer
Sci. 102:2186–2190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang QQ, Xu H, Huang MB, Ma LM, Huang QJ,
Yao Q, Zhou H and Qu LH: MicroRNA-195 plays a tumor-suppressor role
in human glioblastoma cells by targeting signaling pathways
involved in cellular proliferation and invasion. Neuro Oncol.
14:278–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Duan Y and Chen Q: TGF-β1 regulating
miR-205/miR-195 expression affects the TGF-β signal pathway by
respectively targeting SMAD2/SMAD7. Oncol Rep. 36:1837–1844. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang Q, Zhang J, Liu Y, Zhang W, Zhou J,
Duan R, Pu P, Kang C and Han L: A novel cell cycle-associated
lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA
transcript and is a biomarker of progression in glioma. Cancer
Lett. 373:251–259. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zheng J, Liu X, Wang P, Xue Y, Ma J, Qu C
and Liu Y: CRNDE promotes malignant progression of glioma by
attenuating miR-384/PIWIL4/STAT3. Mol Ther. 24:1199–1215. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Brodie S, Lee HK, Jiang W, Cazacu S, Xiang
C, Poisson LM, Datta I, Kalkanis S, Ginsberg D and Brodie C: The
novel long non-coding RNA TALNEC2, regulates tumor cell growth and
the stemness and radiation response of glioma stem cells.
Oncotarget. 8:31785–31801. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li DX, Fei XR, Dong YF, Cheng CD, Yang Y,
Deng XF, Huang HL, Niu WX, Zhou CX, Xia CY and Niu CS: The long
non-coding RNA CRNDE acts as a ceRNA and promotes glioma malignancy
by preventing miR-136-5p-mediated downregulation of Bcl-2 and Wnt2.
Oncotarget. 8:88163–88178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ma CC, Xiong Z, Zhu GN, Wang C, Zong G,
Wang HL, Bian EB and Zhao B: Long non-coding RNA ATB promotes
glioma malignancy by negatively regulating miR-200a. J Exp Clin
Cancer Res. 35:902016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Mills JD, Chen J, Kim WS, Waters PD,
Prabowo AS, Aronica E, Halliday GM and Janitz M: Long intervening
non-coding RNA 00320 is human brain-specific and highly expressed
in the cortical white matter. Neurogenetics. 16:201–213. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zhu G, Wang S, Chen J, Wang Z, Liang X,
Wang X, Jiang J, Lang J and Li L: Long noncoding RNA HAS2-AS1
mediates hypoxia-induced invasiveness of oral squamous cell
carcinoma. Mol Carcinog. 56:2210–2222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Shao W, Li Y, Chen F, Jia H, Jia J and Fu
Y: Long non-coding RNA DLEU1 contributes to the development of
endometrial cancer by sponging miR-490 to regulate SP1 expression.
Pharmazie. 73:379–385. 2018.PubMed/NCBI
|
|
64
|
Li X, Li Z, Liu Z, Xiao J, Yu S and Song
Y: Long non-coding RNA DLEU1 predicts poor prognosis of gastric
cancer and contributes to cell proliferation by epigenetically
suppressing KLF2. Cancer Gene Ther. 25:58–67. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Gao S, Cai Y, Zhang H, Hu F, Hou L and Xu
Q: Long noncoding RNA DLEU1 aggravates pancreatic ductal
adenocarcinoma carcinogenesis via the miR-381/CXCR4 axis. J Cell
Physiol. 234:6746–6757. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Liu T, Han Z, Li H, Zhu Y, Sun Z and Zhu
A: LncRNA DLEU1 contributes to colorectal cancer progression via
activation of KPNA3. Mol Cancer. 17:1182018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Terashima M, Ishimura A, Wanna-Udom S and
Suzuki T: MEG8 long noncoding RNA contributes to epigenetic
progression of the epithelial-mesenchymal transition of lung and
pancreatic cancer cells. J Biol Chem. 293:18016–18030. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Huang JL, Ren TY, Cao SW, Zheng SH, Hu XM,
Hu YW, Lin L, Chen J, Zheng L and Wang Q: HBx-related long
non-coding RNA DBH-AS1 promotes cell proliferation and survival by
activating MAPK signaling in hepatocellular carcinoma. Oncotarget.
6:33791–33804. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Song J, Xu Q, Zhang H, Yin X, Zhu C, Zhao
K and Zhu J: Five key lncRNAs considered as prognostic targets for
predicting pancreatic ductal adenocarcinoma. J Cell Biochem.
119:4559–4569. 2018. View Article : Google Scholar : PubMed/NCBI
|
